Landscapes / Companies
Stelexis BioSciences not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Drugs
2
in active trials
Trials
2 active
2 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Feb 2027Phase 1 trial completes | |||
| Next date | Feb 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
PI3K inhibitor |
Phase 1 | 15 Dec 2027Phase 1 trial completes | |||
| How it works | Blocks PI3K | ||||
| Next date | 15 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | AML, Adult, MDS | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021